Le Lézard

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal ...

Crinetics Pharmaceuticals, Inc. today announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial ...